Dare Bioscience, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
DARE Company Description
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
DARE Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view DARE Smart Score
Score Breakdown
DARE Company Description
Show More
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of DARE by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by DARE's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on DARE's company Twitter account
WallStreetBets
Number of mentions of DARE in WallStreetBets Daily Discussion
DARE News
Recent insights relating to DARE
CNBC Recommendations
Recent picks made for DARE stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in DARE
Corporate Flights
Flights by private jets registered to DARE
Our Analysis